Predictors of Readmission After Breast Reconstruction
Authors:
- Alexei S. MlodinowAMAlexei S. Mlodinow
- Jon P. Ver HalenJHJon P. Ver Halen
- Seokchum LimSLSeokchum Lim
- Khang T. NguyenKNKhang T. Nguyen
- Jessica A. GaidoJGJessica A. Gaido
- John Y.S. KimJKJohn Y.S. Kim
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 71 (4) , 335-341
Abstract
Recent health care legislation institutes penalties for surgical readmissions secondary to complications. There is a paucity of evidence describing risk factors for readmission after breast reconstruction procedures. Patients undergoing breast reconstruction in 2011 were identified in the National Surgical Quality Improvement Program database. Patients were grouped as purely immediate implant/tissue-expander reconstructions or purely autologous reconstruction for analysis. Reconstructions involving multiple types of procedures were excluded due to difficulty with classification. Perioperative variables were analyzed using χ2 and Student t test as appropriate. Multivariate regression modeling was used to identify risk factors for readmission. Of 5012 patients meeting inclusion criteria, 3960 and 1052 underwent implant/expander and autologous reconstructions, respectively. Implant/expander and autologous cohorts experienced similar readmission rates (4.34% vs 5.32%, respectively; P = 0.18). However, autologous reconstructions experienced a higher rate of overall complications than implant/expander reconstructions (19.96% vs 5.86%, respectively; P < 0.05), as well as higher rates of reoperation (9.7% vs 6.5%, respectively; P < 0.05). Common predictors of readmission for implant/expander and autologous cohorts included operative time, American Society of Anesthesiologist class 3 and 4, and superficial surgical site infection. Smoking, sepsis, deep wound infection, organ space infection, and wound disruption were predictive of readmission for implant/expander reconstruction only, whereas hypertension was predictive of readmission after autologous reconstruction only. This is the first study of readmission rates after breast reconstruction. Knowledge of specific risk factors for readmission may improve patient outcomes, steer strategies for optimizing reconstructive outcomes, and minimize readmissions.Keywords
This publication has 38 references indexed in Scilit:
- Comparing thirty-day outcomes in prosthetic and autologous breast reconstruction: A multivariate analysis of 13,082 patients?Journal of Plastic, Reconstructive & Aesthetic Surgery, 2013
- Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or PneumoniaJAMA, 2013
- Human Acellular Dermis versus Submuscular Tissue Expander Breast Reconstruction: A Multivariate Analysis of Short-Term ComplicationsArchives of Plastic Surgery, 2013
- Contributing Variables to Post Mastectomy Tissue Expander InfectionThe Breast Journal, 2012
- Long-Term Reconstructive Outcomes After Expander-Implant Breast Reconstruction With Serious Infectious or Wound-Healing ComplicationsAnnals of Plastic Surgery, 2012
- An Analysis of Immediate Postmastectomy Breast Reconstruction Frequency Using the Surveillance, Epidemiology, and End Results DatabaseThe Breast Journal, 2011
- Rehospitalizations among Patients in the Medicare Fee-for-Service ProgramNew England Journal of Medicine, 2009
- Infectious Complications following Breast Reconstruction with Expanders and ImplantsPlastic and Reconstructive Surgery, 2003
- An Outcome Study of Breast Reconstruction: Presurgical Identification of Risk Factors for ComplicationsAnnals of Surgical Oncology, 2001
- Timing of Pedicle Thrombosis and Flap Loss after Free-Tissue TransferPlastic and Reconstructive Surgery, 1996